PSME4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.111200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.150200E-01
Normal-vs-Stage2
2.451200E-01
Normal-vs-Stage3
7.565600E-02
Normal-vs-Stage4
1.760000E-01
Stage1-vs-Stage2
4.589400E-01
Stage1-vs-Stage3
4.326400E-01
Stage1-vs-Stage4
4.598600E-01
Stage2-vs-Stage3
6.819600E-02
Stage2-vs-Stage4
7.367200E-01
Stage3-vs-Stage4
1.199170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.895380E-01
Normal-vs-AfricanAmerican
3.706800E-01
Normal-vs-Asian
6.113000E-01
Caucasian-vs-AfricanAmerican
8.159600E-01
Caucasian-vs-Asian
2.218000E-01
AfricanAmerican-vs-Asian
6.332400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.170800E-01
Normal-vs-Female
2.199200E-01
Male-vs-Female
8.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.872000E-01
Normal-vs-Age(41-60Yrs)
3.321000E-01
Normal-vs-Age(61-80Yrs)
1.742780E-01
Normal-vs-Age(81-100Yrs)
1.182630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.611000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.378000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.752000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.046400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.697600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.391400E-01
Normal-vs-Daily Drinker
1.137000E-01
Normal-vs-Weekly Drinker
2.666600E-01
Normal-vs-Occasional Drinker
1.989430E-01
Normal-vs-Social Drinker
1.832840E-01
Non Drinker-vs-Daily Drinker
2.911000E-01
Non Drinker-vs-Weekly Drinker
9.216800E-01
Non Drinker-vs-Occasional Drinker
9.874400E-01
Non Drinker-vs-Social Drinker
5.783000E-01
Daily Drinker-vs-Weekly Drinker
2.793600E-01
Daily Drinker-vs-Occasional Drinker
2.648800E-01
Daily Drinker-vs-Social Drinker
8.097800E-02
Weekly Drinker-vs-Occasional Drinker
9.227800E-01
Weekly Drinker-vs-Social Drinker
6.908200E-01
Occasional Drinker-vs-Social Drinker
5.785600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.094000E-01
Normal-vs-Grade 2
2.266200E-02
Normal-vs-Grade 3
2.151800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.072100E-02
Grade 1-vs-Grade 3
2.982400E-02
Grade 1-vs-Grade 4
3.094000E-01
Grade 2-vs-Grade 3
8.342400E-01
Grade 2-vs-Grade 4
2.266200E-02
Grade 3-vs-Grade 4
2.151800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.201800E-01
Normal-vs-NonDiabetic
2.233800E-01
Diabetic-vs-NonDiabetic
5.457400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.088200E-01
Normal-vs-NoPancreatitis
1.789990E-01
Pancreatitis-vs-NoPancreatitis
3.506200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.743000E-01
Normal-vs-N1
2.107000E-01
N0-vs-N1
7.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.430400E-01
Normal-vs-TP53-NonMutant
8.919800E-02
TP53-Mutant-vs-TP53-NonMutant
1.324280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
